Construction of tissue micro array from prostate needle biopsies using the vertical clustering re-arrangement technique

Prostate

Volumn 71, Issue 13, 2011, Pages 1374-1381

  Fridman, Eduard ^a   Daya, Dean ^a   Srigley, John ^a   Whelan, Kaitlyn F ^a   Lu, Jian Ping ^a   Pinthus, Jehonathan H ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

needle biopsy; prostate cancer; tissue microarray

Indexed keywords

APPARATUS; ARTICLE; CLINICAL ARTICLE; EQUIPMENT DESIGN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE NEEDLE BIOPSY; TISSUE MICROARRAY; TISSUE SECTION; VERTICAL CLUSTERING REARRANGEMENT;

BIOPSY, NEEDLE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATIC NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 80051666241     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21352     Document Type: Article

References (18)

1. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Jr, Wallace ME, Kantoff PW, Carroll PR,. Active surveillance for early-stage prostate cancer: Review of the current literature. Cancer 2008; 112: 1650-1659. (Pubitemid 351536825)
2. Grouse LH, Munson PJ, Nelson PS,. Sequence databases and microarrays as tools for identifying prostate cancer biomarkers. Urology 2001; 57: 154-159.
3. Nakagawa T, Kollmeyer TM, Morlan BW, Anderson SK, Bergstralh EJ, Davis BJ, Asmann YW, Klee GG, Ballman KV, Jenkins RB,. A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One 2008; 3: e2318.
4. Titus MA, Gregory CW, Ford OH III, Schell MJ, Maygarden SJ, Mohler JL,. Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer. Clin Cancer Res 2005; 11: 4365-4371. (Pubitemid 40825625)
5. Garraway IP, Seligson D, Said J, Horvath S, Reiter RE,. Trefoil factor 3 is overexpressed in human prostate cancer. Prostate 2004; 61: 209-214. (Pubitemid 39350442)
6. Hofer MD, Kuefer R, Varambally S, Li H, Ma J, Shapiro GI, Gschwend JE, Hautmann RE, Sanda MG, Giehl K, Menke A, Chinnaiyan AM, Rubin MA,. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 2004; 64: 825-829. (Pubitemid 38176879)
7. Lukka H, Hayter C, Julian JA, Warde P, Morris WJ, Gospodarowicz M, Levine M, Sathya J, Choo R, Prichard H, Brundage M, Kwan W,. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 2005; 23: 6132-6138. PubMed PMID: 16135479.
8. Epstein JI, Allsbrook WC, Jr, Amin MB, Egevad LL, ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242. (Pubitemid 41232997)
9. Gleason DF,. Histologic grade, clinical stage, and patient age in prostate cancer. NCI Monogr 1988; (7): 15-18.
10. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM,. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287: 1662-1670. (Pubitemid 34289218)
11. Jhavar S, Corbishley CM, Dearnaley D, Fisher C, Falconer A, Parker C, Eeles R, Cooper CS,. Construction of tissue microarrays from prostate needle biopsy specimens. Br J Cancer 2005; 93: 478-482. (Pubitemid 43080024)
12. McCarthy F, Fletcher A, Dennis N, Cummings C, O'Donnell H, Clark J, Flohr P, Vergis R, Jhavar S, Parker C, Cooper CS,. An improved method for constructing tissue microarrays from prostate needle biopsy specimens. J Clin Pathol 2009; 62: 694-698.
13. Datta MW, Kahler A, Macias V, Brodzeller T, Kajdacsy-Balla A,. A simple inexpensive method for the production of tissue microarrays from needle biopsy specimens: Examples with prostate cancer. Appl Immunohistochem Mol Morphol 2005; 13: 96-103. (Pubitemid 40283810)
14. Singh SS, Mehedint DC, Ford OH III, Maygarden SJ, Ruiz B, Mohler JL,. Feasibility of constructing tissue microarrays from diagnostic prostate biopsies. Prostate 2007; 67: 1011-1018. PubMed PMID: 17476688. (Pubitemid 46983331)
15. Amin M, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W, Srigley JR, Wheeler TM, Montironi R,. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 2005; 216: 20-33.
16. Boccon-Gibod L, van der Kwast TH, Montironi R, Boccon-Gibod L, Bono A,. Handling and pathology reporting of prostate biopsies. Eur Urol 2004; 46: 177-181. (Pubitemid 38902732)
17. Kao J, Upton M, Zhang P, Rosen S,. Individual prostate biopsy core embedding facilitates maximal tissue representation. J Urol 2002; 168: 496-499. (Pubitemid 34793280)
18. Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID,. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001; 87: 797-805. (Pubitemid 34204319)